Barinthus Biotherapeutics Plc Stock Probability of Future Stock Price Finishing Under 0.94
| BRNS Stock | 1.03 0.06 6.19% |
Barinthus |
Barinthus Biotherapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Barinthus Biotherapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Barinthus Biotherapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Barinthus Biotherapeutics had very high historical volatility over the last 90 days | |
| Barinthus Biotherapeutics has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 802 K. Net Loss for the year was (73.63 M) with loss before overhead, payroll, taxes, and interest of (30.12 M). | |
| Barinthus Biotherapeutics generates negative cash flow from operations | |
| Barinthus Biotherapeutics has a frail financial position based on the latest SEC disclosures | |
| About 14.0% of the company shares are held by company insiders |
Barinthus Biotherapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Barinthus Stock often depends not only on the future outlook of the current and potential Barinthus Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Barinthus Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.4 M | |
| Cash And Short Term Investments | 142.1 M |
Barinthus Biotherapeutics Technical Analysis
Barinthus Biotherapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Barinthus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Barinthus Biotherapeutics plc. In general, you should focus on analyzing Barinthus Stock price patterns and their correlations with different microeconomic environments and drivers.
Barinthus Biotherapeutics Predictive Forecast Models
Barinthus Biotherapeutics' time-series forecasting models is one of many Barinthus Biotherapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Barinthus Biotherapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Barinthus Biotherapeutics
Checking the ongoing alerts about Barinthus Biotherapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Barinthus Biotherapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Barinthus Biotherapeutics had very high historical volatility over the last 90 days | |
| Barinthus Biotherapeutics has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 802 K. Net Loss for the year was (73.63 M) with loss before overhead, payroll, taxes, and interest of (30.12 M). | |
| Barinthus Biotherapeutics generates negative cash flow from operations | |
| Barinthus Biotherapeutics has a frail financial position based on the latest SEC disclosures | |
| About 14.0% of the company shares are held by company insiders |
Additional Tools for Barinthus Stock Analysis
When running Barinthus Biotherapeutics' price analysis, check to measure Barinthus Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Barinthus Biotherapeutics is operating at the current time. Most of Barinthus Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Barinthus Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Barinthus Biotherapeutics' price. Additionally, you may evaluate how the addition of Barinthus Biotherapeutics to your portfolios can decrease your overall portfolio volatility.